
    
      This prospective clinical trial aims to evaluate the safety and effectiveness study of
      intravitreal conbercept injection as the primary treatment for exudative circumscribed
      choroidal haemangioma: (1)To evaluate therapeutic effect (including both anatomical and
      functional responses to intravitreal conbercept injection) of intravitreal conbercept
      injectionfor exudative circumscribed choroidal haemangioma; (2)To evaluate the safety
      (including side effects of the eye as well as side effects of system) of intravitreal
      conbercept injection for exudative circumscribed choroidal haemangioma.
    
  